This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Veradigm Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Veradigm's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare Services Industry Growth	7.91%
Revenue growth rate	n/a
Return on equity	n/a
Net Margin	n/a
Last Earnings Update	31 Dec 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Veradigm makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BST:AL21 Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Dec 22	588	-20	169	98
30 Sep 22	1,529	116	360	201
30 Jun 22	1,522	125	354	198
31 Mar 22	1,512	148	323	196
31 Dec 21	577	128	112	84
30 Sep 21	806	-14	181	117
30 Jun 21	1,027	-48	248	142
31 Mar 21	1,255	-96	329	167
31 Dec 20	556	-28	156	79
30 Sep 20	1,428	-143	390	196
30 Jun 20	1,507	-134	398	213
31 Mar 20	1,582	-263	393	231
31 Dec 19	1,633	-238	401	245
30 Sep 19	1,763	-197	405	268
30 Jun 19	1,751	-203	412	257
31 Mar 19	1,748	34	430	268
31 Dec 18	1,618	-39	431	259
30 Sep 18	1,516	70	407	248
30 Jun 18	1,533	54	416	246
31 Mar 18	1,518	-187	405	218
31 Dec 17	1,498	-183	401	202
30 Sep 17	1,714	-210	451	195
30 Jun 17	1,657	-191	433	189
31 Mar 17	1,618	-48	415	190
31 Dec 16	1,386	31	335	179
30 Sep 16	1,470	-2	380	186
30 Jun 16	1,432	3	362	189
31 Mar 16	1,397	10	347	185
31 Dec 15	1,386	-2	339	185
30 Sep 15	1,382	-21	320	180
30 Jun 15	1,373	-41	339	179
31 Mar 15	1,372	-56	345	187

Quality Earnings: Insufficient data to determine if AL21 has high quality earnings.

Growing Profit Margin: Insufficient data to determine if AL21's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if AL21's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare AL21's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if AL21's earnings growth over the past year exceeded the Healthcare Services industry average.

Return on Equity

High ROE: AL21 has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/02/16 10:47
End of Day Share Price	2026/02/10 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veradigm Inc. is covered by 29 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
Matthew Gillmor	Baird
Lawrence Marsh	Barclays